Veterinary surgeons are being called on to help recruit dogs for a clinical study called EPIC - the Evaluation of Pimobendan In dogs with Cardiomegaly caused by pre-clinical mitral valve disease (MVD).
The long-term study, which is supported by Boehringer Ingelheim, will assess whether using pimobendan in the pre-clinical phase of MVD has a benefit in extending the time to the onset of clinical signs. It involves 36 centres globally with the aim of recruiting 360 dogs in total. In order for dogs to be eligible for the study they must:
The three veterinary cardiologists from the UK involved in the randomised, double-blinded, placebo-controlled, parallel group study are Adrian Boswood MA VetMB DipECVIM-ca DVC MRCVS from the Royal Veterinary College (the RVC) in Hertfordshire, Sarah Smith MA VetMB DVC MRCVS from Sarah Smith Cardiology in Derbyshire and Mark Patteson MA VetMB, PhD DVC CertVR MRCVS from Heart Vets at Vale Referrals, Gloucestershire.
Adrian Boswood, veterinary cardiologist from RVC said: "The implications of this study for dogs and their owners could be enormous. If the research shows that pimobendan is effective before clinical signs of MMVD appear, this could lead to a new treatment option for practitioners."
For further information on the study or if you have a dog that may be suitable for the trial, please contact the nearest study investigator - Adrian Boswood on 01707 666605, Sarah Smith on 07515 359241 or Mark Patteson on 01453 547934.
Eurovet has launched Octacillin Pig, a water-soluble amoxicillin powder for treating pneumonia caused by Actinobacillus pleuropneumoniae and meningitis caused by Streptococcus suis.
Octacillin is widely used in poultry and has recently been approved for use in pigs. Eurovet says Octacillin Pig is ideal for delivery via automatic water systems, as it dissolves completely in hard or soft water and remains stable in solution for 12 hours. It has a withhold period of 2 days.
Pneumonia caused by Actinobacillus pleuropneumoniae tends to affect pigs at 8-16 weeks of age and has a very short incubation period of just 12 hours.
Octacillin Pig will be available from early March.
For further information call 01223 257933.
The RCVS Disciplinary Committee has directed that a veterinary surgeon from Berkshire be removed from the Register, following his administration of a prohibited substance to a racehorse and his subsequent attempts to conceal his actions.
At a six-day hearing that concluded yesterday, James Main, a partner in the O'Gorman, Slater, Main & Partners veterinary practice in Newbury, and former lead veterinary surgeon to racehorse trainer Nicky Henderson, faced four charges of serious professional misconduct concerning his treatment of Moonlit Path, a six-year-old mare owned by The Queen.
Three of the charges related to Mr Main breaching British Horseracing Authority (BHA) rules by injecting Moonlit Path with tranexamic acid (TA) on the day she was due to race; the fourth charge related to his dishonest concealment of this treatment in his practice clinical records. Nicky Henderson had himself faced a BHA Inquiry into this case in 2009 and subsequently been sanctioned.
The Committee heard that on 18 February 2009, Mr Henderson's yard requested a veterinary surgeon attend Moonlit Path to administer an injection of Dycenene the following morning. The injection was requested as the mare was prone to exercise-induced pulmonary haemorrhage. Mr Main attended on the morning of 19 February and injected the horse with intravenous tranexamic acid. Moonlit Path raced at Huntingdon later that day, along with the eventual winner, and favourite, Ravello Bay - another horse trained by Mr Henderson. Moonlit Path finished sixth and a urine sample taken from her after the race tested positive for TA.
Of the four charges, Mr Main admitted injecting Moonlit Path with TA on the day she was due to race when he knew this breached the BHA's rule prohibiting any substance other than the horse's usual feed and water being given on race day. However, Mr Main denied knowing that, if tested, a horse would test positive for TA (thereby imposing a strict liability on the trainer); he denied administering a prohibited substance to a horse with the intention to affect that horse's racing performance; and, he denied dishonestly concealing the TA injection by omitting it from his clinical records and referring to it as a 'pre-race check'.
The Committee heard and carefully considered evidence from Mr Henderson and his employees, from BHA investigating officers and its Director of Equine Science and Welfare, from an expert equine physiologist and from Mr Main himself. In its findings, the Committee stated it was "unimpressed by Mr Henderson's evidence and surprised by his apparent lack of knowledge of the rules of racing".
Whilst the Committee accepted Mr Main believed at the time that Moonlit Path would not test positive for TA, it considered he failed to fully inform himself of the medicinal product he was using; especially so as TA does not possess a Marketing Authorisation as a veterinary medicinal product. In so doing, he did not meet his professional obligation to provide Mr Henderson with the information and advice he needed.
The Committee concluded that TA was a prohibited substance and, whilst accepting that Mr Main's concern had solely been for Moonlit Path's welfare, he had actually breached BHA rules by affecting her performance through administering such a substance.
Finally, the Committee found that Mr Main had deliberately concealed the TA injection to Moonlit Path by describing it in his notes as a 'pre-race check' - a protocol developed over several years between the practice and Mr Henderson. Such inaccurate clinical records were in breach of the RCVS Guide to Professional Conduct and led the Committee to conclude he had acted dishonestly. The Committee also found Mr Main "did not act with candour" by claiming to have administered the TA injection the day before the race. On questioning by the Legal Assessor, however, he admitted that he had known that Moonlit Path was racing the same day that he administered the injection.
Professor Sheila Crispin, chairing the Committee, said: "[We] regard it as wholly unacceptable practice that a veterinary surgeon should be party to serious breaches of rules of another regulatory body in the field of animal welfare ... and which go to the very integrity of racing.
"Whilst the findings relate to a single incident, [we] are satisfied that Mr Main's actions amounted to pre-meditated misconduct ... It is highly relevant that Mr Main held positions of responsibility within the racing industry where he was required to uphold the rules and standards of the profession," she added.
Noting Mr Main's "long and hitherto unblemished career as a highly respected equine veterinary surgeon", the Committee accepted Mr Main's evidence that the reason for the administration of tranexamic acid was solely his concern about the welfare of the horse. Nevertheless, it found his evidence was "evasive, lacking in candour and on some aspects of the case his evidence was untrue".
Professor Crispin concluded: "...proven dishonesty has been held to come at the top end of the spectrum of gravity of disgraceful conduct in a professional respect ... Having considered carefully all the mitigation put forward on Mr Main's behalf, [we] have concluded that Mr Main's behaviour was wholly unacceptable and so serious that removal of his name from the Register is required."
The Disciplinary Committee of the Royal College of Veterinary Surgeons has refused an application for restoration to the RCVS Register from a Kent-based former veterinary surgeon struck off in 1994 for disregarding basic hygiene at his professional premises and failing to properly maintain a Controlled Drugs Register or patient records.
In June 1994, the Committee found that Mr Warwick John Seymour-Hamilton, at that time the only veterinary surgeon practising at premises at 9 Orchard Grove, Orpington, Kent, was guilty of disgraceful professional conduct and should have his name removed from the Register. The state and condition of the premises were found to be such as to risk the health and welfare of animals taken to the premises, and bring the profession into disrepute. An application made by Mr Seymour-Hamilton for restoration made in 1995 was refused.
At a restoration hearing on 18 June 2010, Mr Seymour-Hamilton told the Committee that he sought restoration to the Register because he wished to further his research work into plants with potential medicinal properties. Restoration, he said, would improve his professional status by giving him more credibility, particularly in terms of recognition by the medical and veterinary professions.
Mr Seymour-Hamilton said that he had no intention of returning to clinical practice immediately, and neither the Committee nor the College had heard of any adverse conduct by the applicant since his removal.
However, Caroline Freedman, Chairman of the Disciplinary Committee, noted that if Mr Seymour-Hamilton were to be restored, the Committee would have no power to prevent him from returning to general practice.
Mr Seymour-Hamilton's response to questioning by the Committee raised a number of concerns with respect to the future welfare of animals should restoration be granted. He told the Committee that he had not undertaken any relevant Continuing Professional Development in the past 15 years, and said he lacked knowledge of current relevant legislation, for example, the Animals (Scientific Procedures) Act 1986 and basic 'Cascade' prescribing requirements. He also said that he had not read the RCVS Guide to Professional Conduct in the past 15 years and that it would not be satisfactory for him immediately to return to general practice.
Ms Freedman said: "If the Committee were to reinstate the Applicant to the Register, it would have to be satisfied that he is competent and safe to practise immediately. The Committee has an obligation to protect the public and animal welfare and cannot simply accept his assurances that he would take steps to rectify his self-confessed shortcomings at some point in the future."
Having taken all the evidence presented into account, the Committee was not satisfied that Mr Seymour-Hamilton was fit to be restored to the Register and dismissed his application.
Less than a quarter of veterinary students starting their degrees in 2009 were male (24%), according to figures released today in RCVS Facts.
This is up slightly from 23% last year, but down from just over 30% in 1999: ten years before that, the gender balance of new students was approximately 50:50. Meanwhile, 53% of UK-practising veterinary surgeons are female.
RCVS Facts is part two of the RCVS Annual Report, and presents a statistical picture of the veterinary and veterinary nursing professions. Other headline facts include a 21% increase in the number of practice premises registered with the College since 1 April 2009, bringing the total on the Register of Veterinary Practice Premises to 4,821; some 766 veterinary nurse students completing their training and becoming eligible to register (an increase of 28% compared with those eligible to register during the previous two-year period) and an increase of nearly 10% in the number of complaints received about veterinary surgeons, to 739.
Figures are also available for:
The reporting year is 1 April 2009 to 31 March 2010, and part one of the RCVS Annual Report, RCVS Review, takes a more personal look at the activities of the College during the period, through the eyes of some of those involved. Topics include reviews of Extra-Mural Studies and the Practice Standards Scheme, the modular Diploma in Advanced Veterinary Nursing producing the first diplomates, a focus on mental health and wellbeing, fund-raising for the RCVS Trust and the College's joint work with other authorities to bring justice in cases of fraudulent 'veterinary surgeons'.
Both publications are available online at: www.rcvs.org.uk/review and www.rcvs.org.uk/facts.
Graham Gardner has launched its summer collection of scrubwear in the form updated versions of its Urbane and Easiphit Collections, with new colour combinations added to the range.
The Urbane Collection, pictured right, is designed specifically for the female form. Easiephit is a contempary unisex collection.
Simon Ward, Sales Director said: "Scrubwear is becoming a firm favourite with veterinary staff in the UK. The relaxed comfort offered by scrubs is very attractive to staff, and the smart image of colour coded garments is very well received by managers seeking a unified department look. With the increased stocks and increased colour combinations, customers can now get their hands on the new uniforms more quickly than ever before!"
Other colour combinations are still available as special imports. Non-stocked colour requests will be directed to Grahame Gardner's USA Partners and the sales team will ensure that customers are kept updated as to delivery times.
Both Easiephitt and Urbane have also increased their stocked size range. Grahame Gardner now aim to hold sizes from extra, extra small to extra, extra large.
For further information on Urbane, Easiephitt or Grahame Gardner Ltd, please call 0116 255 6326, or visit http://www.grahamegardner.co.uk/.
Intervet/Schering-Plough Animal Health has released diagnostic data which the company says indicates that calf scour problems caused by cryptosporidia are on the increase.
A summary of 2010 results from the company's ScourCheck scheme, which identifies infectious scour pathogens in calf faeces, show the protozoan parasite Cryptosporidium parvum being present in 37% of samples.
Intervet/Schering-Plough ruminant veterinary adviser Drew McGurren said: "Ever since we started testing calf faecal samples in the 1990s, rotavirus and cryptosporidia have always been identified as the two main pathogens implicated in infectious scour problems. But the latest data - and feedback from vets in practice - suggest cryptosporidia incidence is on an upward trend.
"Ten years ago our top line reporting used to refer to rotavirus being implicated in around a third of all infectious calf scour problems and cryptosporidia in roughly a quarter. But in 2009, we detected cryptosporidia in 30% of samples. And this year - from the 250 plus faecal samples we have looked at so far - the incidence seems to be even higher."
Drew stressed that scours caused by cryptosporidia are not always confined to housed calves: "Suckler calves between one and two weeks of age can be very susceptible to infection at grass, particularly if conditions underfoot are muddy around ring feeders. Early May has seen quite a lot of rain, and the parasite thrives in damp conditions."
The major source of cryptosporidia is thought to be either adult cows (which act as carriers without showing signs of disease) or infected scouring calves passing the parasite in their faeces. Drew said: "The infectious dose of the organism is very low and if ring feeders are not moved regularly the disease threat that builds up can be very similar to the housed situation. Faecal contamination of feed and water troughs can also be reduced by raising and covering them.
"Cryptosporidiosis in calves is often seen in combination with other diseases, particularly rotavirus. So vaccinating cows against rotavirus with Rotavec-Corona one to three months pre-calving - as well as a sound colostrum feeding regime and maintaining high hygiene standards - can often tip the balance in your favour."
Intervet Schering-Plough says that if cryptosporidia is diagnosed as the problem, parasite replication and excretion can be reduced with Halocur. This is the only product licensed to treat and prevent cryptosporidiosis. Administered orally to calves after feeding (daily for seven days), it can reduce the severity of diarrhoea and prevent the infection spreading to other calves. Treated calves have also been shown to require fewer antibiotic and anti-inflammatory treatments, as well as less rehydration therapy.
The British Veterinary Association has welcomed the European Parliament vote to improve the labelling of food, including new country of origin labelling and a requirement to label meat from animals slaughtered without stunning (according to certain religious traditions).
The BVA believes that all animals should be stunned before slaughter, for welfare reasons. However, as long as slaughter without stunning is permitted the BVA has argued for any meat from this source to be clearly labelled to enable all consumers to fully understand the choice they are making when buying such products.
Meat from slaughter without stunning currently enters the mainstream food chain without being labelled as such, leaving consumers unaware.
The European Parliament also voted to extend country of origin labelling to all meat, poultry, dairy products and other single-ingredient products as well as all meat, poultry and fish when used as an ingredient in processed food. Importantly, meat labels should indicate where the animal was born, reared and slaughtered.
The UK enjoys some of the highest animal welfare standards in the production of food and the improved country of origin labelling will allow consumers to make a more informed choice.
The BVA is calling for one clear EU welfare label that takes into account the welfare of animals use in food production from birth to slaughter, including the production system, transport and method of slaughter.
Professor Bill Reilly, President of the BVA, said: "This is a huge step forward in improving the welfare of animals at slaughter. The more consumers understand these issues, the more consumer power can make a difference.
"The BVA has argued for some time for meat from animals slaughtered without the more-humane method of stunning should be labelled as such and we are delighted that the European Parliament supports this view.
"However, there are many issues associated with the welfare of animals in food production and the BVA would like to see the development of a clear welfare label that consumers recognise as a mark of higher animal welfare.
"Currently there are too many different labels that mean different things, which can be confusing for shoppers. One higher welfare label would go a long way to improving consumer choice and animal welfare."
Royal Canin has introduced Feline Satiety Support diet in 1.5kg and 3.5kg bags to complement the existing packs of 28 sachets.
Royal Canin veterinary support manager Lepha McCartan said: "As every vet and vet nurse knows, obesity is an ever-increasing problem in cats. We have found that once owners are used to the idea of portion control provided by the existing 28 sachet packs, they are happy to continue to help get their cat's weight down. Bigger packs offer more convenience and value for money for the customer, particularly those who have a few cats with weight issues."
Royal Canin says Feline Satiety Support helps cats feel fuller for longer, offering a greater food volume compared to standard diets. A satisfied cat is less inclined to beg for food, which in turn helps prevent owners giving in to demands from a complaining cat. According to the company, vets recommending Feline Satiety Support have found that the sachet packs help owners understand the correct amount of kibbles per meal, and once this has been established the larger packs offer owners greater choice.
Feline Satiety Support is available in packs of 28 x 20g sachets and 1.5 and 3.5kg bags from all veterinary wholesalers. For more information, contact your Veterinary Business Manager or visit http://www.royalcanin.co.uk/.
CEVA Animal Health has launched a new website - www.dapfordogs.com - to advise veterinary professionals and dog owners about its veterinary behaviour product, D.A.P.
The new site features advice on how to prevent stress at key stages of a dog's life, from puppyhood and socialisation through to adulthood and old age. It also offers an email and SMS monthly reminder service to advise pet owners when to change the refill on their D.A.P. diffuser, a 'find a stockist' search and 'frequently asked questions' section.
In the 'Veterinary Zone', veterinary professionals can order marketing material, download D.A.P. trials and gain further information on news and events including updates on CPD meetings.
To support the site CEVA has created a Facebook page, D.A.P. - The Secret to Happy Dogs, and D.A.P. can now be followed on Twitter: http://twitter.com/dapfordogs/.
The Royal College of Veterinary Surgeons has announced that Andrea Jeffery, the first veterinary nurse to sit on RCVS Council, will take up her place from July this year.
According to the RCVS, the move recognises the increasing importance of veterinary nursing as a profession, and the need for veterinary nurse input on decisions of governance that impact on the whole veterinary team.
The composition of RCVS Council is dictated by the Veterinary Surgeons Act 1966: 24 elected veterinary surgeons, two appointees from each of the six approved veterinary schools and four members appointed by the Privy Council (usually three lay people and the Chief Veterinary Officer).
Within this mix, there has not thus far been a place for a veterinary nurse, however, the vet school appointees do not both have to be veterinary surgeons, and the University of Bristol has nominated Andrea, who will take up her place at RCVS Day on 2 July.
A past Chairman, and elected member of the RCVS Veterinary Nurses Council, Andrea is Programme Director of the Veterinary Nursing and Bioveterinary Science Programme at the University of Bristol. Liz Branscombe will continue as Chairman of the Veterinary Nurses Council, and makes a report to RCVS Council each time it sits - in March, June and November.
Andrea said: "I am very grateful to Bristol for being forward-thinking and enabling a veterinary nurse to sit on RCVS Council in this way. This opportunity gives veterinary nursing a voice on Council and recognises the growing maturity we have as a profession, and the contribution of veterinary nurses to the practice team. I look forward to supporting the work of Liz and the Veterinary Nurses Council."
RCVS President, Sandy Trees said: "The legislation that defines the composition of RCVS Council was put in place when veterinary nursing was in its infancy. However, I am delighted that the University of Bristol has been imaginative enough to choose Andrea as one if its appointees. It is the same spirit of doing as much as we can to modernise, in the absence of new legislation, which has led us to introduce the non-statutary regulation of veterinary nurses and the voluntary Practice Standards Scheme."
Eurovet Animal Health has announced that its levothyroxine tablet hypothyroidism treatments, Forthyron 200 and Forthyron 400, are now available in a scored snap-tab format that allows the tablet to be broken easily into four equal pieces.
Eurovet says this represents a significant benefit to practices, as individual patients often require varying doses due to differences in absorption and metabolism, requiring a wide variety of strengths of medication to be kept in stock. The new presentation means that veterinary surgeons can provide the accurate, customized, individualised approach that these patients require and since just two strengths need to be stocked, it is easier to manage the dispensary. This saves the practice time and money.
Forthyron contains levothyroxine, a synthetic product, chemically identical to naturally occurring T4 that, due to its long duration of action, is a commonly used treatment for hypothyroidism in dogs.
For further information telephone 01223 257933 or email office@eurovet-ah.co.uk www.eurovet-ah.co.uk
Virbac Animal Health has launched an interactive didactic atlas on canine dermatoses for practitioners at www.virbacderm.com.
According to the company, the site offers an original approach to a dermatological investigation, with straightforward flowcharts and enlarged schematics of canine skin.
Product manager Chris Geddes said: "The site brings to life many of the topics covered in the clinical handbook, and may prove particularly valuable as client educational tools. It contains several free educational tools for the dermatologist in general practice."
He added: "Virbacderm.com is already proving extremely useful both for investigating a case and also to boost online CPD. Every aspect of an investigation is included, from effective history taking, to the appropriate time for a biopsy.
"There is also an important section on what is normal for a dog. There's some interesting data on the differences between canine and human skin, and why even "baby shampoo" is not appropriate for use on dogs."
The site also provides compliance tools for clients that are free to download, together with materials provided from Virbac Territory Managers. Chris said: "These aim to ensure that the treatment course prescribed by the vet is in fact being followed correctly and fully - surveys suggest that perhaps only 50% of clients do so."
The Blue Cross is calling for nominations from veterinary practices across the country for its Veterinary Nurse of the Year Award 2010.
The annual award is presented at the British Veterinary Nursing Association (BVNA) Annual Congress in October. It recognises the contribution of veterinary nurses in educating the public about responsible pet ownership and the welfare of pets in the community.
Last year's award was won by Vania Brasseleur for her outstanding contribution to animal welfare, both within her veterinary practice and among the local community in Newport Pagnell, Buckinghamshire
Vania was nominated for the award by student vet nurse and colleague Emily Martin at Astonlee Veterinary Hospital in Newport Pagnell.
Emily said: "Vania is committed to helping student nurses broaden their knowledge and help them on to the path to qualification. Her charity work, serving the public, helping colleagues and of course her nursing abilities are all truly fantastic! I don't think anybody could ask for a better nurse."
Nominations for this year's award can be made by completing the nomination form on The Blue Cross website at: www.bluecross.org.uk/BVNA2010 or by contacting Sally Leathem on 01993 825577. The deadline for nominations is Friday 20 August 2010.
Woodley Equipment Company has become the exclusive Europe-wide distributor for the new Epoc Hand Held Clinical Care Analyser from Epocal Inc
Woodley says the Epoc, developed by the founder of the i-STAT analyser, is the first wireless point of care testing solution to use smart card technology. The Epoc provides immediate blood gas, electrolyte and critical care biochemistry results directly to a hand held PDA (included) and wirelessly interfaces with your in-practice computer. It is a completely affordable analyser that is easy to use and requires no refrigeration of consumables.
Key Features:
For a more information about the Epoc Blood Gas Analyser please email sales@woodleyequipment.com, visit woodleyequipment.com, or call Woodley's customer service team on +44 (0)1204 669033 ~ Option 1
The Royal Veterinary College and The Donkey Sanctuary have launched WikiDonkey, a new information resource about donkeys for veterinary surgeons, nurses and students.
According to The Donkey Sanctuary, WikiDonkey is the first site of its kind and will provide the most comprehensive source of accurate, research-led, practical and regularly-reviewed donkey veterinary information on the web.
WikiDonkey covers all the common conditions of donkeys and identifies the major differences between the management and treatment of donkeys and horses. The site also provides a set of normal physiological, biochemical and haematological parameters, resources that have not always been easily accessible but will undoubtedly prove essential for those treating donkeys.
The Donkey Sanctuary's veterinary project and development manager, Faith Burden said: "When we were approached by WikiVet to sponsor and provide content for their donkey section we were happy to support the initiative as it offers an excellent medium for us to share our expertise with others. We are pleased that these pages will allow veterinary professionals access to the most up-to-date information on donkey specific ailments and treatments."
Nick Short, head of the eMedia unit at the RVC said: "I believe that this unique resource will become an invaluable reference source for vets not only in the UK but all over the world. It will also help ensure that future generations of veterinary students will have access to a reliable and extensive knowledgebase on donkey health and welfare."
To view the Donkey Sanctuary's WikiVet pages, visit http://www.wikivet.net/ or to find out more about the work of The Donkey Sanctuary visit http://www.thedonkeysanctuary.org.uk/
US veterinary equipment manufacturer Midmark is holding a draw for a Matrx VMS anaesthesia machine, open to all UK veterinary practices.
Click this link, enter your details, and the winner will be announced on 7th July 2010.
Merial Territory Managers have taken the first three places at the British Excellence in Sales & Marketing Awards, beating off competition from over 100 other entries, including those from household names such as Virgin, npower and DHL.
Merial's Andi Collins was named Sales Professional of the Year (companies over 50 employees), while her colleagues Emma McAnally and Stephen Booth came second and third respectively. In the eyes of the judges it was their ability to listen, ask questions and then develop insightful business proposals that set them apart.
Merial National Sales Training Manager, Tony Jones said: "At Merial we believe our responsive, well-trained Territory Managers are a great resource for vets. A resource that we are only too happy to see practices use to the fullest extent. We expect our people to do their utmost to find out what a practice's needs really are and then work to deliver the requirements."
The judges recognised the quality of the Merial candidates and their training and also the value this brings to veterinary customers. Andi's commendation said: "Her questioning was very strong, undertaking a fact-find in a relaxed manner which gained empathy and importantly she did not try and propose a solution until she had completed her questioning, to gain a full background of the situation in hand."
Nigel Slater, Head of Companion Animal Sales at Merial said: "I am delighted for Andi, Emma and Stephen. These awards are also a huge endorsement of the training investment we make here at Merial. An investment that independent surveys show is highly regarded by successful veterinary practices."
Burgess Pet Care is investing a six figure sum in its first ever television advertising campaign to promote Supadog and Excel.
Running in tranches across targeted satellite and terrestrial channels up until August 2010, the adverts aim to drive trial and purchase of the products by offering samples through SMS or www.supatasty.co.uk and www.fibrevores.co.uk websites.
Justin Heaton, Head of Marketing, Burgess Pet Care, said: "Burgess Supadog and Excel have seen huge growth this year despite the economic climate for consumers. Pet owners still want to feed their animals quality food but without the expensive price tag. Aligned with our 'Forever Promise', Burgess is committed to making great food that's good for pet's health, is deliciously tasty but at an affordable price. The TV adverts have been a fantastic way to deliver this message and we are extremely pleased with the results they are generating."
The advertising activity is supported by PR, in store POS and a £5,000 golden ticket prize promotion during July and August.
For further information on Supadog and The Excel Feeding Plan visit www.burgesspetcare.co.uk
Fitzpatrick Referrals has carried out a world-first procedure in which an American Bulldog was fitted with a prosthetic hip and femur with a special in-growth attachment which effectively re-attaches the tendons and muscles to the artificial limb.
The procedure took place after 8 year old Roly was diagnosed with cancer in his rear hind leg earlier this year. It involved a highly complex two-hour operation, during which Dr Noel Fitzpatrick, a neuro-orthopaedic veterinary surgeon, replaced the cancerous femur bone and hip joint with a specially constructed artificial prosthesis, while re-attaching the musculature and realigning the relative position of the joint to restore perfect movement to the dog.
The prosthesis was designed through a collaboration between Professor Gordon Blunn, Head of the Centre for Bio-Medical Engineering at UCL's Institute of Orthopaedics and Musculoskeletal Science; veterinary surgeon Noel Fitzpatrick and Jay Meswania from specialist implant manufacturer OrthoFitz.
Professor Blunn said: "What is significant about the design is the way in which it sandwiches tissue and metal together overlaying the gluteal muscles onto the top of the endoprosthetic femur - alternating tendon, synthetic Dacron mesh, tendon, synthetic Dacron mesh, tendon and finally trabecular metal - which has a honeycomb surface resembling a series of small chambers. In this way, the hope is that the Sharpeys fibres which attach tendons of muscles to the bone will grow into the trabecular metal surface and permanently adhere to it."
"This truly remarkable achievement was made possible through the convergence of biomechanics, biology and surgical innovation," said Noel Fitzpatrick. "We tapped into the evidence provided by the CT and MRI scanners we have in place at the practice, so that the data collected about Roly during clinical diagnosis was used to design and construct an artificial femur which exactly mirrored his original limb. It has been constructed rather like a telescope - one section fitting inside the adjoining section, so that we get maximum flexibility and traction during motion."
Noel added: "Hip replacement is common here. We do more than 50 a year, on animals as small as a cat or a Chihuahua. But this hip replacement was special, and to my knowledge, the first of its kind in the world. It's important though to emphasise that this technology must only be employed when it is in the best interests of the individual patient. It's not enough to be able to do something; it must be done for the right reason in every case without exception. It must be ethically right. It's also important to emphasise that Roly will probably not live for a normal lifetime because bone cancer generally spreads to the lungs over time in spite of chemotherapy. However, this technology is equally applicable for dogs and cats affected by trauma who will likely live longer. My job is to look after my patients as best I can and to be honest with their guardians and give them options. What I do is provide pain free functional quality of life for as long as my patient is alive. That's important and that's special, but the decision must remain with each and every individual animal owner".
According to the team, this development also has potentialy life-changing implications for human patients such as motorcycle accident victims, where a key challenge to recovery may be successfully re-attaching the kneecap tendon onto the top of the tibia in the lower leg, and injured sports players with ruptured repairing ruptured tendons.
Click here to view the x-rays of this case in the VetSurgeon Gallery.
Changes to the registration procedure for veterinary surgeons, which are being put forward for approval by the Privy Council, have caused some concern in the profession.
Most contentious is the new requirement for veterinary surgeons to confirm their contact details annually, or face removal from the register.
Judging from the remarks in the VetSurgeon forums, many in the profession see this as just another example of bureaucratic-big-brother-pen-pushing-time-wasting (a perception that probably hasn't been helped by the RCVS stating that the change is driven by the need to meet EU Directive 2006/123/EC). Nor would Lynne Hill's remarks have done anything to calm the situation. She said: "If that [the requirement for vets to confirm their address once a year] is beyond the wit and the capability of supposed professional people that we expect to follow a guide to professional conduct, to act as professionals in everything that they do, then I really despair of this profession.
"I do not see anything wrong with the College asking people to confirm their address year in, year out when they make a payment. And if those people cannot be responsible for doing that then they deserve to go forward to be taken off the Register because, if they can't do that, God only knows what else they may well be doing in their professional lives!"
At face value, it's completely understandable why the new regulation was bound to get members' backs up. I mean, the threat of losing your license to practise because you didn't confirm something which hasn't changed anyway. It's a bit extreme isn't it?
The truth of the matter is probably a little more prosaic:
At present, many members pay registration fees by standing order, and may never have updated their contact details. You could argue that it is only right that the authority changed with regulating veterinary surgeons knows how to get hold of them. If a consequence of this is also that the RCVS is able to work more efficiently and cost-effectively (apart from anything else, it shouldn't have to spend so much time tracking down and chasing non-payers), then so much the better.
The RCVS and VN Councils have each agreed to raise registration and retention fees for the financial year 2011-12 by 2%. This means the annual retention fee for a home-practising veterinary surgeon will increase by £5, and the fee for a veterinary nurse, by £1.
To encourage members who cease to practise to request removal from the Register, rather than simply allow their membership to lapse, the fee for restoration following voluntary removal will be reduced by almost 50%, from £147 to £75.
All fees for the current financial year were, exceptionally, frozen to help mitigate the impact of the difficult economic climate on the veterinary profession. The increases agreed for 2011-12 are below current inflation figures, and in line with the RCVS financial policy of introducing small fee increases on an incremental basis in order to avoid sharp fee hikes resulting from inflationary pressures.
A list of the new fees can be found in the June edition of RCVS News, also available online at www.rcvs.org.uk/rcvsnews.
Neuro orthopaedic veterinary surgeon Noel Fitzpatrick has been having a busy old time: hot on the heels of his world-first procedure to implant a prosthetic hip and femur in an American Bulldog comes the news that he has now fitted a cat with titanium prosthetic paws in another world-first.
Oscar the cat was minding his own business, basking in the late summer sun, when a passing combine harvester chopped off his hind paws.
Unlucky.
However, Oscar's luck turned when his veterinary surgeon, Peter Howarth from St Saviour in Jersey, referred owners Kate and Mike Nolan to Fitzpatrick Referrals to investigate the possibility of giving Oscar a pair of prosthetic paws.
Kate said: "We had to do a lot of soul-searching and our main concern has always been whether this operation would be in Oscar's best interests and would give him a better quality of life". Having decided it would, the Nolans asked Noel to go ahead. And so he came to give the two-year-old cat a pair of new artificial feet in a single, three-hour surgical procedure - something he says has never been done before by any team anywhere in the world.
The revolutionary design of the feet uses custom-made implants to 'peg' the ankle to the foot and mimics the way in which deer antler bone grows through skin. These pegs, or ITAPs (intraosseous transcutaneous amputation prosthetics), were first developed by a team from University College London led by Professor Gordon Blunn, Head of the Centre for Bio-Medical Engineering at UCL's Institute of Orthopaedics and Musculoskeletal Science. Working in partnership with UCL, Fitzpatrick has pioneered the use of these weight-bearing prosthetic implants.
During the operation, the veterinary surgical team had to insert the ITAPs by drilling into one of the ankle bones in each of the back legs - an extremely delicate feat, which could have fractured the ankle joint before the procedure had even begun, and even more challenging because it had to be performed twice. These artificial implants which are attached to the bone at an amputation site are coated with hydroxyapatite, which encourages bone cells to grow onto the metal. The skin then grows over the special umbrella at the end of the ITAP to form a resilient seal against bacteria and potentially fatal infections. The ITAP itself protrudes through the bone and skin, allowing the custom-built artifical paws to be attached securely. Click here to see x-rays and other case photos in the VetSurgeon media gallery.
Following successful surgery in November last year, the focus of the veterinary team has turned to the slow process of rehabilitation and helping Oscar to learn to walk again - firstly using external scaffolding anchored to the tibia to protect the new implants until the ITAPs integrated into the bone and the skin grew onto the ITAP. Remarkably Oscar was trying to stand within a day of the operation and despite some problems with infection that had to be overcome, in less than four months Oscar could stand and bear weight equally on all four limbs. He has since been fitted with a series of prototype new paws to ensure the best possible long term fit.
What makes this procedure so complicated is that Oscar's feet were severed at the junction of the tarsus and metatarsus. Noel said: "The real revolution with Oscar is because we have put a piece of metal and a flange into which skin grows into an extremely tight bone, with very narrow tolerances in the region of nanometres, rather than millimetres. We have then successfully managed to get the bone and skin to grow into the implant and we have developed an exoprosthesis that allows this implant to work as a see-saw on the bottom of an animal's limbs to give him effectively normal gait. Oscar can now run and jump about as cats should do.
Noel Fitzpatrick and the team at Fitzpatrick Referrals are the focus of a new six part documentary series: The Bionic Vet to be broadcast on BBC 1 at 10.45 pm every Wednesday starting on 30 June 2010. The programmes will focus on the multi million pound state-of-the-art vet practice in Surrey as well as the ways in which Noel is pioneering revolutionary new surgical techniques.
In order to prevent tail injury in one dog you'd need to dock 500, according to research published in this week's Veterinary Record.The study1 was based on 138,212 dogs seen by vets at 52 veterinary practices across Britain between March 2008 and March 2009. 281 were treated for a tail injury - a rate of 0.23%, adjusted for sampling. The owners of 224 of these injured dogs, as well as a random sample of 799 owners whose dogs had not been treated for tail injury were sent a questionnaire on dog tail injuries and docking.Only 97 of the owners whose dogs needed treatment and 227 of those whose dogs had not been injured replied.Their responses indicated that around one in three tail injuries (36%; 35 cases) had occurred at home as a result of the dog knocking its tail against a wall, kennel wall or other household object.A further 17.5% (17 cases) were sustained outdoors, while 14.4% (14 cases) were caused by the tail being caught in a door. In 15 (15.5%) other causes were cited; and in 16 (16.5%), the cause was unknown. Almost half of the injuries (44%) were recurrent.Over half the cases were treated with drugs and dressings, but in almost one in three cases, amputation was required. Eleven dogs did not need any treatment.Certain breeds seemed to be more at risk, with springer and cocker spaniels almost six times as likely to sustain a tail injury as labradors and retrievers. Greyhounds, lurchers, and whippets were almost seven times as likely to do so, possibly because of the lack of protective hair on their tails, say the authors. Dogs with a wide angle of wag were also almost four times as likely to be injured in this way, while dogs kept in kennels were more than 3.5 times as likely to sustain a tail injury. Only 35 owners said their dogs had had their tail docked, and on the basis of their overall findings, the authors calculated that tail docking would reduce the risk of injury by 12%.But in absolute terms, 500 dogs would need to have their tail docked in order to prevent one tail injury.
Reference1Risk factors for tail injuries in dogs in Great Britain. G. Diesel, D. Pfeiffer, S. Crispin, and D. Brodbelt. The Veterinary Record 2010 166: 812-817.
Dechra Pharmaceuticals has signed an agreement with Piedmont Pharmaceuticals LLC which gives Dechra exclusive worldwide rights to the sale and distribution of veterinary products which use Piedmont's proprietary soft chew platform to deliver the active ingredient.
The agreement will allow Dechra to conduct studies necessary to achieve regulatory filings and government approvals within the US, Europe and other key countries.
According to Dechra, Piedmont's soft chew formulation is a unique delivery technology which overcomes the traditional problems in formulating a broad range of active drug compounds in a highly palatable chewy treat for both cats and dogs.
Ian Page, CEO of Dechra Pharmaceuticals PLC, said: "We are very excited about licensing this unique delivery technology, which will be the first soft chew product with this new patent pending technology in the veterinary market. The agreement will provide Dechra with the opportunity to expand our presence in the companion animal market with a truly differentiated product."Roland Johnson, Chairman and CEO of Piedmont Pharmaceuticals, said: "This is our initial development partnership for our soft chew technology and we welcome the opportunity to license our technology to Dechra. Our goal is to provide pet owners the added benefit of a tasty treat at medicine time, creating a fun and rewarding interaction, while improving compliance with the vet prescribed treatment regimen."